Dj Oncocyte Corp Com, Inst Holders, 4Q 2024 (Ocx)

This article summarizes the most significant insider buying and selling activities reported on Tuesday, February 11, 2025, for US stocks.

Top Insider Buys:

Berkshire Hathaway Inc . (NYSE:BRKa) (NYSE:BRK.A), led by Warren E. Buffett, has increased its stake in Occidental Petroleum Corp. (NYSE:OXY) by purchasing 763,017 additional shares. The acquisition, completed on February 7, 2025, was made at a weighted average price of $46.8195 per share, totaling approximately $35.7 million. Following this purchase, Berkshire Hathaway now holds 264,941,431 shares of Occidental's common stock through its subsidiary, National Indemnity Company. Occidental currently trades at a P/E ratio of 11.8x and offers a dividend yield of 1.81%, with a 22% dividend growth in the last twelve months.

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) saw significant insider buying from Venrock Healthcare Capital Partners (WA:CPAP). The investment firm acquired a total of 104,489 shares across three transactions between February 7 and February 11, 2025, at prices ranging from $9.14 to $9.29 per share. The total investment amounted to approximately $967,144. Following these acquisitions, Venrock's total holdings in KalVista Pharmaceuticals increased to 5,117,285 shares. The company, valued at $458 million, has shown strong momentum with a 9.45% return year-to-date.

Oncocyte Corp (NASDAQ:OCX) reported a notable insider purchase by Chief Financial Officer James Andrea S. On February 7, 2025, Andrea acquired 97,561 shares of Oncocyte common stock at a price of $2.05 per share, totaling approximately $200,000. This purchase was made through a private placement. Following the transaction, Andrea's direct ownership in Oncocyte stands at 151,231 shares. The company, currently trading at $2.37 with a market cap of $39.6 million, is rated as having WEAK financial health.

Top Insider Sells:

Rumble Inc. (NASDAQ:RUM) saw significant insider selling activity from multiple executives. Robert Arsov, a director, sold 12,350,025 shares at $7.50 per share, totaling approximately $92.6 million. CEO Christopher Pavlovski sold 9,999,283 shares at the same price, bringing in about $74.9 million. Chief Content Officer Ramolo Claudio sold 6,269,731 shares for approximately $47 million, while CFO Brandon Alexandroff sold 8,872,259 shares for about $66.5 million. Director Ryan Milnes also sold 24,978,210 shares, totaling approximately $187.34 million. These sales were part of Rumble's self-tender offer, which concluded on February 7, 2025. Despite these sales, Rumble's stock has shown significant volatility, with a 94% surge over the past six months.

Investors should stay tuned to insider buying and selling activities as they can provide valuable insights into a company's prospects. While insider purchases may signal confidence in the company's future, insider sales don't necessarily indicate a lack of faith, as they can occur for various personal reasons. However, large-scale selling by multiple insiders, as seen in Rumble's case, may warrant closer attention to the company's overall health and future outlook.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This article summarizes the most significant insider buying and selling activities reported for US stocks on Monday, February 10, 2025.

Top Insider Buys:

Oncocyte Corp (NASDAQ:OCX):

Broadwood Partners, L.P. significantly increased its stake in Oncocyte Corp, a $34.6 million market cap company. The firm acquired a total of 5,165,695 shares through two transactions. The first involved purchasing 660,207 shares at $2.05 per share in a registered direct offering, totaling approximately $1.35 million. The second, larger transaction consisted of 4,505,488 shares at the same price, amounting to roughly $9.24 million, conducted through a private placement agreement. Analysts have set price targets ranging from $4.00 to $4.25 for OCX, suggesting potential upside from current levels.

Mach Natural Resources LP (NASDAQ:MNR):

BCE-Mach Aggregator LLC invested approximately $79.9 million in Mach Natural Resources LP by purchasing 5,161,290 common units at $15.50 per unit. This investment comes as MNR, valued at $1.66 billion, offers an attractive dividend yield of ~15%. The purchase increases BCE-Mach Aggregator's holdings to 74,287,410 shares, reflecting a strategic commitment to the crude petroleum and natural gas sector. William W. McMullen, Managing Partner of Bayou City Energy Management, plays a key role in this transaction, although he disclaims beneficial ownership beyond his pecuniary interest.

Alset Inc. (NASDAQ:AEI):

Chan Heng Fai Ambrose, CEO of Alset Inc., acquired 291,060 shares over two days at average prices of $0.99 and $1.03. The total value of these acquisitions amounts to approximately $294,149. Following these transactions, Ambrose now directly owns 6,329,498 shares, with an additional 319,000 shares held indirectly through HFE Holdings Limited. This increases his beneficial ownership to 6,648,498 shares, highlighting his continued confidence in the company's prospects.

Sionna Therapeutics , Inc. (NASDAQ:SION):

RA Capital Management purchased 1,124,000 shares of Sionna Therapeutics at $18 per share, totaling $20.25 million. The stock currently trades at $22.24, representing a 23.6% premium to RA Capital's purchase price. Additionally, OrbiMed Advisors LLC, a director at Sionna Therapeutics, acquired 550,000 shares at $18 per share, amounting to $9.9 million. OrbiMed also converted shares of Series B and Series C convertible preferred stock into common stock as part of the company's IPO process.

Top Insider Sells:

Amgen Inc . (NASDAQ:AMGN):

Jonathan P. Graham, Executive Vice President and General Counsel at Amgen Inc., sold 25,045 shares at an average price of $293.12, generating approximately $7.34 million. Graham also exercised stock options to acquire the same number of shares at $156.35 per share, which were set to expire on May 3, 2026.

Arista Networks , Inc. (NYSE:ANET):

Kenneth Duda, Chief Technology Officer and Senior Vice President of Software (ETR:SOWGn) Engineering, sold shares totaling approximately $9.25 million. The transactions took place at prices ranging from $114.02 to $117.14 per share. These sales were conducted under a Rule 10b5-1 trading plan.

Ares Management Corp (NYSE:ARES):

Kipp deVeer, Co-President of Ares Management Corp, sold 79,933 shares worth approximately $14.9 million. The shares were sold at prices ranging from $187.08 to $191.58 each. Following these transactions, deVeer holds 1,150,000 restricted units set to vest in installments under an equity incentive plan.

Tesla, Inc. (NASDAQ:TSLA):

Kimbal Musk, a director at Tesla, sold 74,077 shares at prices between $367.868 and $368.43 per share, totaling approximately $27.6 million. Following these transactions, Musk retains ownership of 1,463,220 shares of Tesla.

Meta Platforms, Inc. (NASDAQ:META):

Mark Zuckerberg, Chairman and CEO of Meta Platforms, sold shares worth approximately $39.7 million. The sales were executed through two entities: CZI Holdings, LLC, and the Chan Zuckerberg Initiative Foundation, with prices ranging from $712.36 to $724.28 per share.

Investors should stay tuned to insider buying and selling activities as they can provide valuable insights into a company's prospects. While insider transactions alone should not be the sole basis for investment decisions, they can offer clues about management's confidence in the company's future performance and potential upcoming developments. However, it's essential to consider these transactions in the context of broader market trends, company fundamentals, and individual investment goals.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.